At AAPS PharmSci 360 2025, held from Nov. 9–12 in San Antonio, Texas, Corey Bloom, PhD, associate director, CMC (chemistry, ...
InMed Pharmaceuticals Inc., a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug ...
New NIAID Non-Dilutive Funding Award of up to US $40Million with US$90 Million in Pending Proposals Across Multiple Infectious Disease Programs LIKMEZ® (ATI-1501): Building Commercial Momentum in the ...
As chief strategy officer and senior vice president of ambulatory services at UCI Health, Tatyana Popkova leads strategy formulation, network growth and marketing for one of California’s largest ...
Q3 2025 Earnings Call November 13, 2025 4:30 PM ESTCompany ParticipantsMarDee Haring-Layton - Chief Accounting ...
An announcement from Ramm Pharma ( ($TSE:RAMM) ) is now available. RAMM Pharma Corp. has received minority shareholder approval for a proposed ...
Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2026
New NIAID Non-Dilutive Funding Award of up to US $40Million with US$90 Million in Pending Proposals Across Multiple ...
Positive 9-month follow-up data for NDV-01 showed a 92% overall response rate at any time in non-muscle invasive bladder cancer (NMIBC), with favorable overall safety ...
Detailed price information for Outlook Therapeutics Inc (OTLK-Q) from The Globe and Mail including charting and trades.
Doseology Sciences Inc. (CSE: MOOD | PINK: DOSEF | FSE: VU70) ("Doseology" or the "Company"), an innovator in precision-formulated oral stimulants ...
Fiera Cosmetics has created a solution with their All-in-Wonderâ„¢ Concealer + Foundation that addresses these exact concerns, which explains why so many women are making the switch from products like ...
Patient Enrollment on Track in Global Phase 3 Program for Treatment of Hepatitis C Virus (HCV), Topline Results from North ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results